Publications

Mitra, S., Jain, A., Ting, J. Y., Ben Fadel, N., Drolet, C., Abou Mehrem, A., Soraisham, A. S., Jasani, B., Louis, D., Lapointe, A., Dorling, J., Khurshid, F., Hyderi, A., Kumaran, K., Toye, J., Harabor, A., Weisz, D. E., Stavel, M., Morin, A., … Piedboeuf, B. (2026). Pharmacologic therapies for patent ductus arteriosus in extremely preterm infants. JAMA Network Open, 9(6).

Mitra, S., Hebert, A., Castaldo, M. P., Disher, T., El-Naggar, W., Dhillon, S., Alhassen, Z., Koo, J., Katheria, A. C., Hyderi, A., Kumaran, K., Ting, J., Surak, A., Larocque, J., Pepper, D., Hornberger, L., Makoni, M., Weisz, D. E., Jain, A., … Thabane, L. (2026). Selective early medical treatment of the patent ductus arteriosus in extremely low gestational age infants: A pilot randomised controlled trial (SMART-PDA). Archives of Disease in Childhood – Fetal and Neonatal Edition.

Mitra, S., Finan, E., & Manhas, D. (2026). Minimizing blood loss and need for transfusions in newborns. Paediatrics & Child Health, 31(4), 377–383.

Mitra, S., Scrivens, A., Fiander, M., Disher, T., Weisz, D.E. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants (2025). Cochrane Database of Systematic Reviews, 6(6), CD013278

Mitra, S., Bischoff, A. R., Sathanandam, S., Lakshminrusimha, S., & McNamara, P. J. (2024). Procedural closure of the patent ductus arteriosus in preterm infants: a clinical practice guideline. Journal of Perinatology, 44(10): 1402-1408

Mitra, S., Whitehead, L., Smith, K., Maclean, B., Nixon, R., Veysey, A., Campbell-Yeo, M., Kuhle, S., Gale, C., Soll, R., Dorling, J., & Johnston, B. C. (2023). Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in extremely preterm infants: a clinical practice guideline incorporating family values and preferences. Archives of Disease in Childhood – Fetal and Neonatal Edition, 109(3): 232-238

Mitra, S., de Boode, W. P., Weisz, D. E., & Shah, P. S. (2023). Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews. The Cochrane Database of Systematic Reviews, 4(4), CD013588

Mitra, S., Hatfield, T., Campbell-Yeo, M., Dorling, J., Johnston, B.C. (2023) Health-related values and preferences of former preterm infants and families of preterm infants on use of prophylactic cyclo-oxygenase inhibitor drugs. JAMA Network Open, 6(3), e232273. 

Mitra, S., Gardner, C.E., MacLellan, A., Disher, T., Styranko, D.M., Kuhle, S., Johnston, B.C., Dorling, J. (2022). Prophylactic cyclo‐oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta‐analysis. The Cochrane Database of Systematic Reviews, 4(4), CD013846

Mitra, S., Florez, I.D., Tamayo, M.E., Mbuagbaw, L., Vanniyasingham, T., Veroniki, A.A., Zea, A.M., Zhang, Y., Sadeghirad, B., Thabane, L. (2018). Association of Placebo, Indomethacin, Ibuprofen and Acetaminophen with Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis. JAMA. 319(12): 1221-1238

For a complete list of publications, please visit PubMed.